Amgen, the world's largest biotechnology company, announced on Wednesday plans to build a new manufacturing plant in Singapore.
Thousand Oaks, California-based Amgen said it plans to invest around $200 million in the project, which will initially focus on the production of antibody-based drugs.
Construction, in the Tuas Biomedical Park area of Singapore, is expected to begin in the next few months.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Compelling solutions through strategic partnerships
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Ineos CEO Ineos calls on European politicians to save the chemical industry.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
